CD8A and cancer: The SSTR2-high groups have a higher median of central memory CD8 T cell scores, activated CD8 T cell scores, and effector memory CD8 T cell scores in most cancers (central memory CD8 T cell scores: 96.5%; activated CD8 T cell scores: 96.15%; effector memory CD8 T cell scores: 96.5%; Figures 2B–D), suggesting better T cell infiltration may be possible in SSTR2-high groups.